Prof Mbanya addresses the gathering.
19.2pc UAE population has diabetes
Dubai , May 5, 2012
Diabetes is a serious concern for the UAE as 19.2 per cent of the population has been diagnosed with the disease, according to a new data from the International Diabetes Federation (IDF).
These startling figures were released at a event accredited by the Ministry of Health and the Dubai Health Authority and which was attended by participants from major private and public hospitals across the UAE.
The new IDF data also highlighted the diabetes associated consequences for both the patients and the economy.
Servier Pharmaceutical Company, a leading French medical firm, yesterday launched the 'Physicians’ Educational Day' event to highlight the diabetes epidemic in the emirates.
The physicians meeting also discussed key issues on how to diagnose diabetes effectively, assess the risk of cardiovascular damage in diabetic patients, and how to effectively manage medication to avoid renal and cardiovascular complications while keeping diabetes in check.
'Latest international guidelines recommend that physicians use Gliclazide MR (Diamicron MR 60mg) to control diabetes and its complications after the drug’s strong performance in the Advance trial, considered the largest ever trial in the history of diabetes,' said Professor Yehia Ghanem, the professor of Internal Medicine, Diabetes and Metabolism Department Faculty of Medicine, Alexandria University, Egypt.
'Advance’s new results, announced at the World Diabetes Congress in December 2011, showed that the regular use of Gliclazide MR can avoid kidney failure in 65 per cent of diabetic patients with type 2 diabetes (2 out of 3) compared to groups treated with other medications,' he added.
IDF president Prof Jean Claude Mbanya said Diabetes was a serious concern for the UAE, and the medical community was realizing the need for effective and trusted partners in innovation to deliver drugs that effectively control diabetes and treat its consequences.
'Reputed drugs such as Gliclazde MR and Metformin are commonly prescribed by healthcare providers in the country, in addition to newer medications which have less scientific evidence about their ability to protect against diabetes complications, or safety in long term use,' remarked Mbanya, also the professor of Medicine and Endocrinology Faculty of Medicine, University of Yaoundé, Cameroon.
“Diabetes is an epidemic that costs lives and also imposes economic burdens. The medical and scientific communities must cooperate in treating this epidemic with resources and medications that offer scientific proof of efficacy and show discernable results in improving patient well-being,” he added.-TradeArabia News Service
More Health & Environment Stories
- SARS virus claims one more victim in Saudi
- New support group comes to overeaters' rescue
- RAK Hospital launches urinary clinic for women
- NBAD backs Emiratis on Antarctica trip
- Cut sugar intake drastically urges WHO
- Al khaliji to fund Qatar recycling plant
- Qatar researcher in 360km breast cancer run
- New facilitator to open in DHCC
- Many countries lack capacity to prevent hearing loss
- QUIT NOW: Passive smoking hurts kids' arteries
- San Francisco to ban plastic water bottles
- GSK wins home toothpaste award for Sensodyne
- E-integration vital to GCC healthcare industry
- Fakih IVF unveils two new genetic tests
- 2 die from H1N1 in Oman
- Al Noor Hospitals targets domestic growth
- Medical panel on the way in Bahrain
- 40pc of UAE adults ‘have hypertension’
- Saudi diabetics urged to stay away from camels
- GCC readies plan to fight heart diseases
- Bahrain opens sickle cell hospital
- Hazardous waste focus for Oman summit
- Infectious viruses to be tracked by satellite in UAE
- Mafraq Hospital names new surgery chief
- Saudi health ministry seals BMJ partnership
- Need for medical simulation training highlighted
- UAE-France discuss healthcare collaboration
- Seha focus on patient centred services
- Saudi-Tokyo firms in wastewater technology JV
- Leading experts at Dubai diabetes conference